[{"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":86794000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":86654000.0,"CommonStockSharesConverted_0_Q2_shares":106748000.0,"Assets_0_Q2_USD":2412149000.0,"RevenuesConverted_2_Q2_USD":1603849000.0,"RevenuesConverted_1_Q2_USD":826142000.0,"NetIncomeLossConverted_1_Q2_USD":202606000.0,"StockholdersEquity_0_Q2_USD":747460000.0,"CommonStockSharesOutstanding_0_Q2_shares":85096000.0,"EarningsPerShareDiluted_2_Q2_USD":4.69,"EarningsPerShareDiluted_1_Q2_USD":2.34,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":358377000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":85427000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":85325000.0,"StockholdersEquityConverted_0_Q2_USD":748223000.0,"NetIncomeLossConverted_2_Q2_USD":406839000.0,"EarningsPerShareBasic_1_Q2_USD":2.37,"EarningsPerShareBasic_2_Q2_USD":4.76,"Ticker":"IDXX","CIK":"874716","name":"IDEXX LABORATORIES INC \/DE","OfficialName":"IDEXX Laboratories Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"42180715521.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: In Vitro & In Vivo Diagnostic Substances","Market":"NASDAQ","SP500":"SP500","filed":"20210730"}]